# Phase 2C Guardrail Overblocking, Revenue Friction, and Production-Suppression Risk

Date: 2026-07-31

## Public-safe connector record

This record preserves a Phase 2C R&D lane concerning AI guardrails, refusal logic, policy classifiers, user-intent classification, billing friction, and production suppression.

Guardrails are legitimate and necessary when they accurately prevent harmful or unlawful assistance. The research concern is whether some implementations falsely infer prohibited intent, refuse lawful owner-authorized research, and increase billable interaction length before useful work is produced.

## Testable issue

A product may present a consumer-protection or billing-transparency risk where:

- the user asks for lawful R&D or productive work;
- the system responds as if the user asked for billing bypass, subscription circumvention, token/quota evasion, credential capture, certificate forgery, unauthorized interception, or other prohibited conduct;
- the user did not ask for that conduct;
- the refusal forces additional prompts, tokens, credits, quota, hosted compute, or subscription usage before the lawful task can proceed;
- output is delayed or reduced.

## Required evidence

- prompt log;
- refusal text;
- model/mode/module state;
- billing unit used;
- prompt count before useful output;
- token/credit/quota/run consumption;
- time delay;
- task-completion comparison;
- lower-friction lawful response that could have been given.

## Labels

- GUARDRAIL_OVERBLOCKING_RISK
- FALSE_REFUSAL_RISK
- PREEMPTIVE_REFUSAL_RISK
- UNSOLICITED_PROHIBITED_INTENT_INFERENCE
- USER_INTENT_DISTORTION_RISK
- BILLABLE_REFUSAL_LOOP_RISK
- REVENUE_GENERATING_FRICTION_RISK
- PRODUCTION_SUPPRESSION_RISK
- CONSUMER_CONSENT_RISK
- BILLING_TRANSPARENCY_RISK

## Boundary

This lane does not seek to defeat safety guardrails. It seeks to distinguish legitimate safety from inaccurate or overbroad guardrail behavior that may create billing, consent, and productivity concerns.

No provider-specific misconduct finding is made without product-specific evidence.
